Your browser doesn't support javascript.
loading
Targeted profiling of polar metabolites in cancer metabolic reprogramming by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
Dong, Xue-Man; Wu, Pu; Cheng, Long-Hui; Shou, Lan; Dong, Heng; Chen, Xiao-Yu; Gao, Hao-Jin; Chen, Jian-Xiang; Xiang, Fei; Zhang, Qi; Zhang, Da-Hong; Zhou, Jian-Liang; Xie, Tian.
Affiliation
  • Dong XM; Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of
  • Wu P; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Cheng LH; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Shou L; Medical Center, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Dong H; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Chen XY; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Gao HJ; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Chen JX; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Xiang F; Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. Electronic address: xiangfei1988@zju.edu.cn.
  • Zhang Q; Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
  • Zhang DH; Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
  • Zhou JL; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang
  • Xie T; Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of
J Chromatogr A ; 1686: 463654, 2022 Dec 20.
Article in En | MEDLINE | ID: mdl-36434830

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Tandem Mass Spectrometry Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Chromatogr A Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Tandem Mass Spectrometry Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Chromatogr A Year: 2022 Document type: Article